Ptashkin RN, Pagan C, Yaeger R, Middha S, Shia J, O'Rourke KP, Berger MF, Wang L, Cimera R, Wang J et al..
2017.
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.. Mol Cancer Res. 15(6):708-713.
Becattini S, Littmann ER, Carter RA, Kim SG, Morjaria SM, Ling L, Gyaltshen Y, Fontana E, Taur Y, Leiner IM et al..
2017.
Commensal microbes provide first line defense against infection.. J Exp Med. 214(7):1973-1989.
Vergote IB, Smith DC, Berger R, Kurzrock R, Vogelzang NJ, Sella A, Wheler J, Lee Y, Foster PG, Weitzman R et al..
2017.
A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma.. Eur J Cancer. 83:229-236.
Peterson LW, Philip NH, DeLaney A, Wynosky-Dolfi MA, Asklof K, Gray F, Choa R, Bjanes E, Buza EL, Hu B et al..
2017.
RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.. J Exp Med. 214(11):3171-3182.